Po-653-02 mortality related to antiarrhythmic choice among patients with atrial fibrillation and left ventricular hypertrophy

Heart Rhythm(2022)

Cited 0|Views0
No score
Abstract
Current atrial fibrillation (AF) guidelines recommend only amiodarone or dronedarone as antiarrhythmic drugs (AAD) in patients with left ventricular hypertrophy (LVH), due to a postulated pro-arrhythmic risk. However, there are limited clinical data to support these recommendations.
More
Translated text
Key words
Atrial Fibrillation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined